Charles Schwab’s Azora Therapeutics AZR Stock Holding History
Bought
Maintained
Sold
Other funds holding AZR
Charles Schwab's AZR Position: Q3 2022 in Review
Charles Schwab sold out of Azora Therapeutics (AZR) in Q3 2022, closing a stake of 34 shares — an estimated $29K sold.
Charles Schwab first reported a position in AZR in Q3 2021 and held it in 3 quarters. The position peaked at $50K in Q3 2021. 26 funds tracked by Wall St. Rank hold AZR as of Q3 2022.
- Charles Schwab reported no remaining Azora Therapeutics position as of Q3 2022 after selling out during the quarter.
- Charles Schwab sold 34 Azora Therapeutics shares in Q3 2022, an estimated $29K.
- Charles Schwab first reported a position in Azora Therapeutics in Q3 2021 and held it in 3 quarters.
- Charles Schwab's Azora Therapeutics position peaked at $50K in Q3 2021.
- 26 funds tracked by Wall St. Rank held Azora Therapeutics as of Q3 2022.
Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.